Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups
Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
10/2009
10/22/2009US20090264448 Pyrazolo[1,5-a]pyrimidines, processes, uses and compositions
10/22/2009US20090264420 Organic compounds
10/22/2009US20090264414 Amide Derivatives and Pharmaceutical Use Thereof
10/22/2009US20090264409 Bicyclic Heterocyclic p-38 Kinase Inhibitors
10/22/2009US20090264406 3-methyl-imidazo[1,2-b]pyridazine derivatives
10/22/2009US20090264405 Cetp Inhibitors
10/22/2009US20090263933 Field effect transistor and method of producing same
10/22/2009US20090263322 Octahydro-indolizine and quinolizine and hexahydro-pyrrolizines
10/21/2009EP2109614A1 Enantioselective synthesis of 6-amino-7-hydroxy-4, 5, 6, 7-tetrahydro-imidazo [4, 5, 1-jk][1]-benzazepin-2 [1h]-one and zilpaterol
10/21/2009EP2109613A2 Polymorphs of eszopiclone malate
10/21/2009EP1697043B1 Pentasil-structuer zeolithic material the production and use thereof
10/21/2009EP1608374B9 2-phenoxy- and 2-phenylsulfomamide derivatives with ccr3 antagonistic activity for the treatment of asthma and other inflammatory or immunological disorders
10/21/2009EP1450811B1 Compounds specific to adenosine A1 and A3 receptors and uses thereof
10/21/2009EP1346993B1 Lactam compounds and medical use thereof
10/21/2009CN101563351A Substituted pyrazolo-quinazoline derivatives, process for their preparation and their use as kinase inhibitors
10/21/2009CN101563350A Amorphous form of n-{2-fluoro-5-[3-(thiophene-2-carbonyl)-pyrazolo [1,5-a]pyrimidin-7-yl]-phenyl-N-methyl-acetamide
10/21/2009CN101563349A Haloalkyl-substituted pyrimidinone derivatives
10/21/2009CN101563347A Vasopressin V1a antagonists
10/21/2009CN101560214A 4-amino-6-phenyl-pyrrolo[2, 3-d]pyrimidine derivatives
10/21/2009CN101560213A Polycyclic compound functioned as inhibitor of enzyme parp, vegfr2 and mlk3 and the application
10/21/2009CN101560212A Preparation for 1,2,4-triazolo[1,5-a]pyrimidine-2-ethyl thioether disubstituted derivative and application thereof
10/21/2009CN101560211A Preparation for 1,2,4-triazolo[1,5-a]pyrimidine-2-ethyl thioether monosubstituted derivative and application thereof
10/21/2009CN101560206A Intermediate of pemetrexed disodium, preparation method thereof and method for preparing pemetrexed disodium thereby
10/20/2009US7605288 2,5-(Aminocarbonylalkylene-(3,5-dihydroxy,6-halo-1,2-phenylene)-carbonyloxyalkylene)-)-p-quinone; chimera, mimetics of radicicol and geldanamycin; anticarcinogenic agents; antitumor agents; decreased toxicity; increased solubility and selectivity; enzyme inhibitors
10/20/2009US7605264 Nitrogen-containing tetracylic bridged ring compounds; treating obesity, diabetes and inflammatory or immune associated diseases; nuclear factor kappa beta (NF-KB)
10/20/2009US7605175 Inhibitors of cyclin-dependent kinases, compositions and uses related thereto
10/20/2009US7605165 Phenylalanine derivatives
10/20/2009US7605160 Inhibit tyrosine kinase activity of Trk receptors; antiproliferative agents, anticancer agents; cancer, psoriasis or rheumatoid arthritis; N4-pyrazol-5-yl-pyrrolo[2,1-f] [1,2,4]triazine-2,4-diamines
10/20/2009US7605157 Tricyclic tetrahydroquinoline antibacterial agents
10/20/2009US7605155 Enzyme inhibitors from pyrazolo[1,5a]pyrimidine as enzyme inhibitors; cyclin dependent kinases (CDKs) inhibitors; cancer, inflammation and arthritis; neurodegenerative diseases such Alzheimer's; cardiovascular, viral and fungal diseases
10/20/2009US7605111 Herbicides
10/20/2009CA2532925C Azolo triazines and pyrimidines
10/20/2009CA2450122C Novel heterocyclic antibacterial compounds
10/20/2009CA2378183C Antibacterial heterobicyclic substituted phenyl oxazolidinones
10/20/2009CA2245066C Zinc-phthalocyanines and corresponding conjugates, their preparation and use in photodynamic therapy and as diagnostic agents
10/15/2009WO2009126584A1 Gem-disubstituted and spirocyclic amino pyridines/pyrimidines as cell cycle inhibitors
10/15/2009WO2009126515A1 Compounds and compositions as protein kinase inhibitors
10/15/2009WO2009126293A2 Potent chimeric nrti-nnrti bifunctional inhibitors of hiv-1 reverse transcriptase
10/15/2009WO2009126166A1 Optical data recording medium including a multi-layered markable coating
10/15/2009WO2009125415A1 Amorphous form of sildenafil citrate
10/15/2009WO2009124996A1 Anhydrous crystal form of orvepitant maleate
10/15/2009WO2009124965A1 PYRROLO[2,3-d]PYRIMIDIN-2-YL-AMINE DERIVATIVES AS PKC-THETA INHIBITORS
10/15/2009WO2009124853A1 New ruthenium complexes as catalysts for metathesis reactions
10/15/2009WO2009124692A1 New substituted spiro[cycloalkyl-1,3'-indol]-2'(1'h)-one derivatives and their use as p38 mitogen-activated kinase inhibitors.
10/15/2009WO2009098715A3 Novel pyrazolo [3, 4 -d] pyrimidine derivatives as anti -cancer agents
10/15/2009WO2009097405A3 Compounds and methods for preparing diazaspiro derivatives
10/15/2009WO2009093934A3 Substituted 3-sulphonyl-[1,2,3]triazolo [1,5-a]pyrimidines-antagonists of serotonin 5-ht6 receptors and methods for the production thereof
10/15/2009WO2009093269A9 Novel heterocyclic compounds
10/15/2009WO2009087667A3 Crystalline polymorphic forms of zopiclone, processes for their preparation and their pharmaceutical compositions
10/15/2009WO2009016460A8 Pyrazole compounds and their use as raf inhibitors
10/15/2009US20090258899 Derivatives of pyrrolizine, indolizine and quinolizine, preparation thereof and therapeutic use thereof
10/15/2009US20090258886 Heteroalkyl linked pyrimidine derivatives
10/15/2009US20090258881 Aryl-substituted polycyclic amines, method for the production thereof, and use thereof as a medicament
10/15/2009US20090258877 Triazolotriazines and triazolopyrazines and their use
10/15/2009US20090258874 Pyrazolo-heteroaryl compounds
10/15/2009US20090258870 Novel ansamitocin derivatives
10/15/2009US20090258868 Heterocyclic aspartyl protease inhibitors
10/15/2009US20090258867 Pyrazolo[1,5-a] pyrimidine compounds as cb1 receptor antagonist
10/15/2009US20090258864 Pyrimidine-2-amine compounds and their use as inhibitors of jak kinases
10/15/2009US20090258862 Niacin receptor agonists, compositions containing such compounds and methods of treatment
10/15/2009US20090258858 Muscarinic acetylcholine receptor antagonists
10/15/2009US20090258856 Imidazopyridazinone and imidazopyridone derivatives, the preparation thereof and their use as pharmaceutical compositions
10/15/2009US20090258855 Bicyclic triazoles as protein kinase modulators
10/15/2009US20090256476 Oleds doped with phosphorescent compounds
10/15/2009CA2721119A1 Anhydrous crystal form of orvepitant maleate
10/15/2009CA2720946A1 Compounds and compositions as protein kinase inhibitors
10/15/2009CA2719531A1 New ruthenium complexes as catalysts for metathesis reactions
10/15/2009CA2716202A1 Pyrrolo[2,3-d]pyrimidin-2-yl-amine derivatives as pkc-theta inhibitors
10/14/2009EP2108641A1 New substituted spiro[cycloalkyl-1,3'-indo]-2'(1'H)-one derivatives and their use as p38 mitogen-activated kinase inhibitors
10/14/2009EP2108020A2 1-h-pyrazolo[3,4b]pyrimidine derivatives and their use as modulators of mitotic kinases
10/14/2009EP2108019A2 1-h-pyrazolo[3,4b]pyrimidine derivatives and their use as modulators of mitotic kinases
10/14/2009EP1636235B1 Pyridinylpyrazolopyrimidinone derivatives as pde 7 inhibitors
10/14/2009EP1397137B1 Hydantion derivatives as inhibitors of matrix metalloproteinases
10/14/2009CN101558507A Material for organic electroluminescent device and organic electroluminescent device
10/14/2009CN101558072A Pyrazolo [3, 4 -d] pyrimidine p38 map kinase inhibitors
10/14/2009CN101558071A Substituted quinazolines
10/14/2009CN101558070A Triazolo-pyridazine protein kinase modulators
10/14/2009CN101558062A Indolylmaleimide derivatives as kinase inhibitors
10/14/2009CN101557826A Therapeutic agent for urinary tract disease
10/14/2009CN100549014C Triazolopyrimidine derivatives as glycogen synthase kinase 3 inhibitors
10/14/2009CN100548992C Microbiocidal (e.g. fungicidal) 1,2,3-triazole derivatives
10/13/2009US7601840 Carboline derivatives useful in the inhibition of angiogenesis
10/13/2009US7601837 Quinoline derivatives and their use as 5-HT6 ligands
10/13/2009US7601836 Pyrido[2,3-D]pyrimidine inhibitors of phosphodiesterase (PDE) 7
10/13/2009US7601833 Process for preparing substituted 5-amino-pyrazolo-[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidines
10/13/2009US7601753 Pyrrolidine melanocortin-specific compounds
10/13/2009US7601734 Cyclic amine compound
10/13/2009US7601730 Carboxylic acid derivatives, their preparation and use
10/13/2009US7601727 Such as 3-{4-Methyl-3-[methyl-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-amino]-piperidin-1-yl}-3-oxo-propionitrile; janus kinase 3 inhibitors; immunosuppressive agents; asthma
10/13/2009US7601726 Substituted pyrazolo[3,4-d]pyrimidines as p38 MAP kinase inhibitors
10/13/2009US7601724 Substituted pyrazolo[1,5-a]pyrimidines as protein kinase inhibitors
10/13/2009US7601719 Compounds, methods and pharmaceutical compositions for inhibiting PARP
10/13/2009US7601718 1,5-Dihydro-pyrazolo[4,3-c]pyridazin-6-one derivatives; glycogen synthase kinase-3 (CSK) inhibitors; nervous system, psychological, and neurodegenerative disorders; diabetes, psychiatry, multiple sclerosis (MS), myocardial infarction, reperfusion/ischemia, alopecia, and stroke
10/13/2009US7601717 Pterin analogs
10/13/2009US7601713 Kinase inhibitors and their uses
10/13/2009US7601710 Preparation of hymenialdisine derivatives and use thereof
10/13/2009US7601709 Macrocyclic hepatitis C serine protease inhibitors
10/13/2009US7601337 Delivery of antipsychotics through an inhalation route
10/13/2009CA2521846C Reverse-turn mimetics and method relating thereto
10/13/2009CA2429844C Mch antagonists and their use in the treatment of obesity
1 ... 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 ... 573